-
Article | 2017.01.05
MOOC In the footsteps of Zika… approaching the unknown
L’Institut Pasteur coproduit avec l’Université de Genève (UNIGE), l’Université Paris-Descartes et le Centre Virchow-Willermé, un MOOC centré sur le virus Zika, intitulé « In the footsteps of Zika…approaching the unknown ».Ce MOOC vise à faciliter la compréhension des enjeux autour du virus Zika, en proposant une approche interdiscplinaire incluant...
-
Fiche maladie | 2016.06.21
Zika
The Zika virus is a Flavivirus mainly transmitted by the bite of infected mosquitoes of the genus Aedes. It causes Zika virus disease.
-
Article | 2017.01.05
MOOC Medical entomology - Insect vectors and transmission of pathogens
The MOOC Medical entomology focuses on the insects and arthropods that impact human health as well as the associated diseases, such as malaria, dengue, Zika, Lyme borreliosis, Chagas disease…
-
News | 2016.04.24
How could Zika enter Europe?
Researchers at the Institut Pasteur have assessed the transmission potential of four populations of Aedes mosquitoes in circulation on the island of Madeira and southern France with a view to examining various possible scenarios for the introduction of Zika virus to Europe. Their work suggests that the Aedes aegypti mosquito present in Madeira is more likely to promote local transmission of Zika...
-
Document de presse | 2016.04.25
How could Zika enter Europe?
Researchers at the Institut Pasteur have assessed the transmission potential of four populations of Aedes mosquitoes in circulation on the island of Madeira and southern France with a view to examining various possible scenarios for the introduction of Zika virus to Europe. Their work suggests that the Aedes aegypti mosquito present in Madeira is more likely to promote local transmission of Zika...
-
News | 2016.02.29
Zika: Confirmation of a causal link between the Zika virus and Guillain-Barré Syndrome
Using data collected in French Polynesia, researchers from the Institut Pasteur, the CNAM (Conservatoire national des arts et métiers), the Institut Louis Malardé, the French Polynesia Hospital Centre, and the Public Hospitals of Paris (AP-HP), have shown that infection by the Zika Virus (ZIKV) increases the likelihood of contracting Guillain-Barré Syndrome (GBS), a severe form of limb paralysis...
-
Document de presse | 2016.03.01
Zika: Confirmation of a causal link between the Zika virus and Guillain-Barré Syndrome
Using data collected in French Polynesia, researchers from the Institut Pasteur, the CNAM (Conservatoire national des arts et métiers), the Institut Louis Malardé, the French Polynesia Hospital Centre, and the Public Hospitals of Paris (AP-HP), have shown that infection by the Zika Virus (ZIKV) increases the likelihood of contracting Guillain-Barré Syndrome (GBS), a severe form of limb paralysis...
-
News | 2016.06.22
Antibodies that are effective against both dengue and Zika viruses
Scientists have identified antibodies that can efficiently neutralize both the dengue virus and the Zika virus. The description of the binding site for these antibodies on the viral envelope, identical for both viruses, could lead to the development of a universal vaccine that offers simultaneous protection against dengue and Zika virus disease.
-
News | 2016.03.15
Zika and microcephaly: first trimester of pregnancy most critical
A new analysis of data from the 2013-2014 Zika epidemic in French Polynesia by scientists from the Institut Pasteur, Paris, and their French Polynesian colleagues has confirmed the incidence of grouped cases of microcephaly and quantified the risk of microcephaly associated with the virus. Using innovative mathematical modeling techniques, their research shows that the risk of microcephaly is...
-
Document de presse | 2016.06.23
Antibodies that are effective against both dengue and Zika viruses
Scientists from the Institut Pasteur and the CNRS[1], in collaboration with Imperial College London and the University of Vienna, Austria, have identified antibodies that can efficiently neutralize both the dengue virus and the Zika virus. The description of the binding site for these antibodies on the viral envelope, identical for both viruses, could lead to the development of a universal...
